Sandler Capital Management Exact Sciences Corp Call Options Transaction History

Sandler Capital Management

  • $698 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 16, 2021
BUY
$99.61 - $142.12 $8.96 Million - $12.8 Million
90,000 New
90,000 $11.9 Million
Q3 2018

Nov 14, 2018
SELL
$48.29 - $80.6 $7.24 Million - $12.1 Million
-150,000 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$37.84 - $69.96 $5.68 Million - $10.5 Million
150,000 New
150,000 $8.97 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Sandler Capital Management Portfolio

Follow Sandler Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandler Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Sandler Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email